CompletedNot Applicable

Acute Cardioversion Versus Wait And See-approach for Symptomatic Atrial Fibrillation in the Emergency Department

Netherlands437 participantsStarted 2014-10

Plain-language summary

A symptomatic episode of the heart rhythm disorder 'atrial fibrillation' (AF) is a frequent reason for visits to the emergency department. Currently, in the majority of cases, immediate (electrical or pharmacological) cardioversion is chosen, while atrial fibrillation terminates spontaneously in 70% of the cases within 24 hours. A wait-and-see approach with rate-control medication only, and when needed cardioversion within 48 hours of onset of symptoms, could be effective, safe and more cost-effective than current standard of care and could lead to a higher quality of life.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * ECG with atrial fibrillation at the emergency department * Heart rate \> 70bpm * Symptoms most probable due to atrial fibrillation * Duration of symptoms \< 36 hours * \> 18 years of age * Able and willing to sign informed consent * Able and willing to use MyDiagnostick Exclusion Criteria: * Signs of myocardial infarction on ECG * Hemodynamic instability (systolic blood pressure \< 100mm Hg, heart rate \> 170 bpm) * Presence of pre-excitation syndrome * History of Sick Sinus Syndrome * History of unexplained syncope * History of persistent AF (episode of AF lasting more than 48 hours) * Acute heart failure * Currently enrolled in another clinical trial * Deemed unsuitable for participation by attending physician

What they're measuring

12-lead ECG

Timeframe: 4 weeks

Trial details

NCT IDNCT02248753

SponsorMaastricht University Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-11

View on ClinicalTrials.gov More Atrial Fibrillation trials